Financial reports
10-Q
2024 Q1
Quarterly report
1 Feb 24
10-K
2023 FY
Annual report
22 Nov 23
10-Q
2023 Q3
Quarterly report
2 Aug 23
10-Q
2023 Q2
Quarterly report
26 Apr 23
10-Q
2023 Q1
Quarterly report
6 Feb 23
10-K
2022 FY
Annual report
23 Nov 22
10-Q
2022 Q3
Quarterly report
27 Jul 22
10-Q
2022 Q2
Quarterly report
27 Apr 22
10-Q
2022 Q1
Quarterly report
4 Feb 22
10-K
2021 FY
Annual report
24 Nov 21
Current reports
8-K
Submission of Matters to a Vote of Security Holders
12 Feb 24
8-K
Updates Fiscal Year 2024 Financial Guidance
1 Feb 24
8-K
Results of Operations and Financial Condition
8 Nov 23
8-K
Updates Fiscal Year 2023 Financial Guidance
2 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
26 Jul 23
8-K
Surmodics Receives FDA Approval for the SurVeilâ„¢ Drug-Coated Balloon
20 Jun 23
8-K
Regulation FD Disclosure
8 Jun 23
8-K
Updates Fiscal Year 2023 Financial Guidance
26 Apr 23
8-K
Regulation FD Disclosure
28 Mar 23
8-K
Regulation FD Disclosure
15 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
12 May 23
S-3
Shelf registration
12 May 23
S-8
Registration of securities for employees
23 Feb 22
S-8
Registration of securities for employees
18 Dec 20
S-3
Shelf registration
22 May 20
S-8
Registration of securities for employees
3 May 19
S-3
Shelf registration
31 Jul 14
SC TO-I/A
Issuer tender offer statement (amended)
11 Sep 12
SC TO-I/A
Issuer tender offer statement (amended)
6 Sep 12
SC TO-I/A
Issuer tender offer statement (amended)
27 Aug 12
Proxies
DEF 14A
Definitive proxy
18 Dec 23
DEFA14A
Additional proxy soliciting materials
18 Dec 23
DEF 14A
Definitive proxy
19 Dec 22
DEFA14A
Additional proxy soliciting materials
19 Dec 22
DEFA14A
Additional proxy soliciting materials
20 Dec 21
DEF 14A
Definitive proxy
20 Dec 21
DEFA14A
Additional proxy soliciting materials
22 Dec 20
DEF 14A
Definitive proxy
22 Dec 20
DEFA14A
Additional proxy soliciting materials
23 Dec 19
DEF 14A
Definitive proxy
23 Dec 19
Other
EFFECT
Notice of effectiveness
30 May 23
SD
Conflict minerals disclosure
25 May 23
UPLOAD
Letter from SEC
19 May 23
CORRESP
Correspondence with SEC
19 May 23
SD
Conflict minerals disclosure
27 May 22
SD
Conflict minerals disclosure
25 May 21
EFFECT
Notice of effectiveness
1 Jun 20
CORRESP
Correspondence with SEC
27 May 20
UPLOAD
Letter from SEC
27 May 20
CT ORDER
Confidential treatment order
18 Jun 18
Ownership
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
JOSE H BEDOYA
12 Feb 24
4
DAVID DANTZKER
12 Feb 24
4
RONALD B KALICH SR
12 Feb 24
4
SUSAN E KNIGHT
12 Feb 24
4
Lisa Wipperman Heine
12 Feb 24
SC 13G
MORGAN STANLEY
9 Feb 24
SC 13G/A
Trigran Investments, Inc.
9 Feb 24
4
SUSAN E KNIGHT
7 Feb 24
SC 13G/A
Soleus Capital Master Fund, L.P.
2 Feb 24